Janone Inc
NASDAQ:JAN
Intrinsic Value
JanOne, Inc. focuses on developing treatments for diseases that cause severe pain. [ Read More ]
The intrinsic value of one JAN stock under the Base Case scenario is 1.15 USD. Compared to the current market price of 3.08 USD, Janone Inc is Overvalued by 63%.
Valuation Backtest
Janone Inc
Run backtest to discover the historical profit from buying and selling JAN stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
This note will be permanently deleted.
Balance Sheet Decomposition
Janone Inc
Current Assets | 1.2m |
Cash & Short-Term Investments | 61k |
Receivables | 331k |
Other Current Assets | 799k |
Non-Current Assets | 17.4m |
Long-Term Investments | 180k |
Intangibles | 17.2m |
Current Liabilities | 8.1m |
Accounts Payable | 2m |
Accrued Liabilities | 2.4m |
Short-Term Debt | 600k |
Other Current Liabilities | 3m |
Non-Current Liabilities | 2.9m |
Long-Term Debt | 504k |
Other Non-Current Liabilities | 2.4m |
Earnings Waterfall
Janone Inc
Revenue
|
0
USD
|
Operating Expenses
|
-20.6m
USD
|
Operating Income
|
-20.6m
USD
|
Other Expenses
|
510k
USD
|
Net Income
|
-20m
USD
|
Free Cash Flow Analysis
Janone Inc
USD | |
Free Cash Flow | USD |
JAN Profitability Score
Profitability Due Diligence
Janone Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Janone Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
JAN Solvency Score
Solvency Due Diligence
Janone Inc's solvency score is 23/100. The higher the solvency score, the more solvent the company is.
Score
Janone Inc's solvency score is 23/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
JAN Price Targets Summary
Janone Inc
According to Wall Street analysts, the average 1-year price target for JAN is 4 USD .
Ownership
JAN Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
JAN Price
Janone Inc
Average Annual Return | -16.03% |
Standard Deviation of Annual Returns | 48.83% |
Max Drawdown | -98% |
Market Capitalization | 27.9m USD |
Shares Outstanding | 9 056 160 |
Percentage of Shares Shorted | 2.02% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
JanOne, Inc. focuses on developing treatments for diseases that cause severe pain. The company is headquartered in Las Vegas, Nevada and currently employs 161 full-time employees. The company went IPO on 2006-02-22. The firm is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. In addition, through Its subsidiaries ARCA Recycling, Connexx, and ARCA Canada, the Company is engaged in the business of recycling household appliances in North America by providing appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs. Also, through its GeoTraq Inc. subsidiary, it is engaged in the development, design of wireless transceiver modules with technology that provides LBS directly from global Mobile IoT networks. The company operates through three operating segments: Biotechnology, Recycling, and Technology. Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. Recycling segment is an appliance recycling program.
Contact
IPO
Employees
Officers
The intrinsic value of one JAN stock under the Base Case scenario is 1.15 USD.
Compared to the current market price of 3.08 USD, Janone Inc is Overvalued by 63%.